Abstract:Objective To explore the expression of triggering receptor expresses on myeloid cells-2 (TREM-2) in low-grade glioma (LGG) and its impact on patient survival by bioinformatics, and to provide potential targets for the early detection, early diagnosis and treatment of LGG.Methods The online websites GEPIA2 and UALCAN were used to analyze the expression difference of TREM-2 in LGG tumor tissue and normal tissue, the relationship with clinicopathological characteristics such as age, gender, race, tumor grade, and the effects of abnormal expression of TREM-2 in LGG tumor tissue on the overall survival rate in LGG patients. KEGG pathway enrichment analysis of TREM-2-related genes was conducted by DAVID 6.8 software. The correlation between TREM-2 expression and tumor purity and degree of immune cell infiltration was analyzed using the TIMER database.Results Compared with normal tissues, the expression of TREM-2 in LGG tumor tissues was significantly higher than that in the normal group (P<0.5), and it was correlated with tumor grade and histological type (P<0.001) and not correlated with the patient's age, gender and race (P>0.05). Survival analysis showed that TREM-2 was closely related to the prognosis of LGG. The higher the expression of LGG, the lower the overall survival rate of patients (P=0.00025 and P=0.0029), and disease free survival rate also decreased (P=0.015). Pathway enrichment results showed that the gene pathways positively related to TREM-2 mainly involved tuberculosis, cancer pathway, phagosome, etc., and the negatively related gene pathways mainly involved MAPK signaling pathway, neuroactive ligand-receptor. The expression of TREM-2 was positively correlated with the infiltration level of 6 kinds of immune cells in the tumor microenvironment.Conclusion The expression of TREM-2 in LGG tumor tissues is significantly increased, and is related to the survival rate of patients. It is a potential target for the diagnosis and treatment of LGG.